Advertisement
UK markets close in 4 hours 34 minutes
  • FTSE 100

    8,295.94
    +82.45 (+1.00%)
     
  • FTSE 250

    20,390.33
    +225.79 (+1.12%)
     
  • AIM

    777.29
    +5.76 (+0.75%)
     
  • GBP/EUR

    1.1646
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2541
    -0.0023 (-0.18%)
     
  • Bitcoin GBP

    51,144.50
    +19.44 (+0.04%)
     
  • CMC Crypto 200

    1,325.98
    -39.15 (-2.87%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.16
    -0.32 (-0.41%)
     
  • GOLD FUTURES

    2,321.60
    -9.60 (-0.41%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,301.85
    +126.64 (+0.70%)
     
  • CAC 40

    8,022.13
    +25.49 (+0.32%)
     

Is Abbott Laboratories a Good Dividend Stock to Buy Now?

Is Abbott Laboratories a Good Dividend Stock to Buy Now?

It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-paying stock, in particular, is getting a lot of positive attention. Abbott Laboratories (NYSE: ABT) reported fourth-quarter earnings on Thursday, Jan. 26. Since then, Sanford C. Bernstein, Raymond James, Stifel Nicolaus, and Barclays have all raised their price targets on the healthcare conglomerate.